Rsa Insurance Dividends - RSA

Rsa Insurance Dividends - RSA

Buy
Sell
Best deals to access real time data!
Level 2 Basic
Monthly Subscription
for only
£62.08
Silver
Monthly Subscription
for only
£17.37
UK/US Silver
Monthly Subscription
for only
£30.59
VAT not included
Stock Name Stock Symbol Market Stock Type Stock ISIN Stock Description
Rsa Insurance Group Plc RSA London Ordinary Share GB00BKKMKR23 ORD GBP1.00
  Price Change Price Change % Stock Price Last Trade
-0.60 -0.09% 674.40 16:35:16
Open Price Low Price High Price Close Price Previous Close
675.20 674.40 677.00 674.40 675.00
more quote information »
Industry Sector
NONLIFE INSURANCE

Rsa Insurance RSA Dividends History

Announcement Date Type Currency Dividend Amount Period Start Period End Ex Date Record Date Payment Date Total Dividend Amount
27/02/2020FinalGBX15.631/12/201831/12/201905/03/202006/03/202014/05/202023.1
01/08/2019InterimGBX7.531/12/201831/12/201905/09/201906/09/201911/10/20190
28/02/2019FinalGBX13.731/12/201731/12/201807/03/201908/03/201917/05/201921
02/08/2018InterimGBX7.331/12/201731/12/201806/09/201807/09/201812/10/20180
22/02/2018FinalGBX1331/12/201631/12/201701/03/201802/03/201818/05/201819.6
02/08/2017InterimGBX6.631/12/201631/12/201707/09/201708/09/201713/10/20170
23/02/2017FinalGBX1131/12/201531/12/201602/03/201703/03/201712/05/201716
04/08/2016InterimGBX531/12/201531/12/201608/09/201609/09/201614/10/20160
25/02/2016FinalGBX731/12/201431/12/201503/03/201604/03/201613/05/201610.5
06/08/2015InterimGBX3.531/12/201431/12/201510/09/201511/09/201515/10/20150
26/02/2015FinalGBX231/12/201331/12/201405/03/201506/03/201515/05/20152
01/08/2013InterimGBX2.2831/12/201231/12/201325/09/201327/09/201322/11/20132.28
20/02/2013FinalGBX3.931/12/201131/12/201203/04/201305/04/201324/05/20137.31
02/08/2012InterimGBX3.4131/12/201131/12/201226/09/201228/09/201223/11/20120
23/02/2012FinalGBX5.8231/12/201031/12/201128/03/201230/03/201225/05/20129.16
04/08/2011InterimGBX3.3431/12/201031/12/201110/08/201112/08/201125/11/20110
24/02/2011FinalGBX5.731/12/200931/12/201002/03/201104/03/201103/06/20118.82
05/08/2010InterimGBX3.1231/12/200931/12/201011/08/201013/08/201026/11/20100
25/02/2010FinalGBX5.3331/12/200831/12/200903/03/201005/03/201004/06/20108.25
06/08/2009InterimGBX2.9201/07/200931/12/200912/08/200914/08/200927/11/20090
26/02/2009FinalGBX4.9831/12/200731/12/200804/03/200906/03/200907/05/20097.71
07/08/2008InterimGBX2.7330/12/200730/06/200813/08/200815/08/200808/12/20010
27/02/2008FinalGBX4.5331/12/200631/12/200705/03/200807/03/200801/04/20087.01
08/08/2007InterimGBX2.4830/12/200630/06/200715/08/200717/08/200730/11/20070
08/03/2007FinalGBX4.1231/12/200531/12/200614/03/200716/03/200701/06/20075.87
10/08/2006InterimGBX1.7530/12/200530/06/200616/08/200618/08/200630/11/20060
09/03/2006FinalGBX3.0531/12/200431/12/200515/03/200617/03/200602/06/20064.74
11/08/2005InterimGBX1.6930/12/200430/06/200517/08/200519/08/200530/11/20050
10/03/2005FinalGBX2.9631/12/200331/12/200416/03/200518/03/200502/06/20054.61
12/08/2004InterimGBX1.6530/12/200330/06/200418/08/200420/08/200430/11/20040
11/03/2004FinalGBX2.931/12/200231/12/200317/03/200419/03/200403/06/20044.9
03/09/2003InterimGBX230/12/200230/06/200310/09/200312/09/200328/11/20030
06/03/2003FinalGBX231/12/200131/12/200230/04/200302/05/200330/05/20036
08/08/2002InterimGBX430/12/200130/06/200221/10/200223/10/200229/11/20020
28/02/2002FinalGBX7.231/12/200031/12/200124/04/200226/04/200231/05/200216
02/08/2001InterimGBX8.830/12/200030/06/200105/09/200107/09/200130/11/20010
01/03/2001FinalGBX17.231/12/199931/12/200014/03/200116/03/200101/06/200126
03/08/2000InterimGBX8.830/12/199930/06/200004/09/200008/09/200001/12/20000
02/03/2000FinalGBX16.331/12/199831/12/199913/03/200017/03/200001/06/200024.7
05/08/1999InterimGBX8.430/12/199830/06/199906/09/199910/09/199901/12/19990
04/03/1999FinalGBX15.231/12/199731/12/199815/03/199919/03/199901/06/199923
06/08/1998InterimGBX7.830/12/199730/06/199817/08/199821/08/199801/12/19980

Top Dividend Posts

DateSubject
18/11/2020
09:47
squeamish1: Mute swans exist but there is no such thing as a 'mute point'... As regards the offer think rival bid now the Board has approved is very slim. Takeover at this premium due to how the geographic profile of RSA fits the buyers. Expect Denmark to be immediately sold on once the bidders take joint control. Gap between current price and takeover now just reflects time value of money
05/11/2020
18:22
loganair: The Proposal comprises 685 pence in cash per RSA share, plus payment by RSA of the announced interim dividend of 8 pence per share (the "Interim Dividend").
05/11/2020
17:06
loganair: I consider this to be an exceedingly good offer a total of 693p. The 20 year high for RSA is 681p on 25th June 2018. A few years back Zurich made an offer of 525p for RSA which RSA management turned down saying they're looking for an offer of 600p which Zurich walked away from. It seems to me RSA management were rare in that after turning down the Zurich offer their share price rose to well above the offer as for many companies after turning down an offer often the share price falls significantly then remains at the lower price.
05/11/2020
16:44
sphere25: Wow, another bid. Sure are flying in of late: "The Board of RSA Insurance Group plc ("RSA" or "the Company") notes the recent media speculation regarding the possibility of an offer for the entire issued share capital of the Company and confirms that on 2 October 2020 it received a proposal from Intact Financial Corporation ("Intact") and Tryg A/S ("Tryg") (together, the "Consortium") regarding a possible offer for the Company ("the Proposal"). This may or may not lead to an offer being made for RSA. The Proposal comprises 685 pence in cash per RSA share, plus payment by RSA of the announced interim dividend of 8 pence per share (the "Interim Dividend"). "
20/7/2020
08:45
loganair: Shore Capital sees ‘buying opportunity’ in hard-hit RSA: RSA (RSA) has been one of the hardest hit insurers during the Covid-19 crisis but Shore Capital maintains its business model makes it a defensive play in a recessionary environment. Analyst Alan Devlin retained his ‘buy’ recommendation and target price of 600p on the shares, which closed at 432.8p on Friday. ‘RSA has been one of the hardest hit UK insurance stocks from Covid-19 after suspending its final 2019 dividend due to its potential exposure from UK business interruption claims, losing £1bn of market cap,’ he said. Devlin said the stock presented a ‘buying opportunity’, arguing that ‘RSA’s business and geographical mix make its earnings and dividends defensive from both Covid-19 and a recessionary environment’. He expected the 2019 and 2020 full year dividend would be paid ‘likely together in early 2021’.
08/5/2020
07:54
loganair: Numis upgrades ‘oversold̵7; RSA: Numis has upgraded insurer RSA (RSA), arguing the shares look ‘heavily oversold’. Analyst Nick Johnson upgraded his recommendation from ‘hold’ to ‘buy’ with a target price of 605p on the shares, which rose 6.6% to 393.6p yesterday. He said ‘general trends in the business look to have continued from 2019’ with operating profit up double-digits in the first quarter. Although it will have to make provisions of £25m to cover Covid-19-related travel claims, RSA ‘looks to be benefiting from extensive reinsurance protection’. ‘We think RSA shares look heavily oversold,’ he said. ‘Given the recent share price fall we move from “hold” to “buy”.’
17/1/2020
17:18
loganair: Forget gold and Bitcoin! I’d invest in this FTSE 100 stock to get rich and retire early RSA: Insurance business RSA (LSE: RSA) is another FTSE 100 share that could deliver impressive total returns in the long run. Its recent trading update showed that it is making progress in its aim to improve the customer experience. It has also delivered improved underwriting results, despite market conditions being competitive. The stock is forecast to post a rise in net profit of 8% in the next financial year. Since it trades on a price-to-earnings (P/E) ratio of 12.1, it seems to offer good value for money at the present time when compared to its wider sector. This suggests that it may deliver a rising share price over the coming years. Furthermore, RSA is expected to raise its dividends per share by around 11% in the next two financial years. This puts it on a forward dividend yield of 4.6% from a shareholder payout that is expected to be covered twice by net profit. Therefore, it could become increasingly attractive from an income investing standpoint, which may lead to greater investor demand for its shares. As such, now could be the right time to buy it as its growth and income investing prospects look set to improve.
17/12/2019
14:20
loganair: The State Pension is unlikely to be sufficient for most retirees to enjoy financial freedom in older age. It amounts to just £8,767 per annum, which is less than a third of the average UK salary. As such, buying dividend shares could be a sound idea. They may be able to produce an inflation-beating passive income over the long run that reduces your reliance on the State Pension. Since the FTSE 100 currently has a 4%+ dividend yield, now could be the right time to buy large-cap shares. With that in mind, here is a FTSE 100 dividend stock that could improve your long-term income investing future. RSA: The recent third-quarter update from insurer RSA (LSE: RSA) highlighted an improvement in its underwriting performance compared to previous quarters. This contributed to growth in its operating profit in the first nine months of the year, with the business being on track to deliver full-year results that are in line with its expectations. RSA is seeking to improve its customer proposition, while growing its business where underwriting conditions allow. This is expected to catalyse its bottom-line growth over the next couple of years, with earnings growth of around 16% expected in the next financial year. Alongside a modest rating, this produces an attractive price-to-earnings growth (PEG) ratio of 0.9. In terms of the company’s income investing appeal, it currently yields 4%. Its shareholder payouts are covered 1.7 times by net profit, while a rapid growth rate in profitability could lead to a large increase in dividends in the coming years. As such, with dividend investing potential and a valuation that suggests it offers growth at a reasonable price, there could be an appealing opportunity to buy the stock today for the long term.
07/3/2019
09:43
loganair: RSA shares gain as UBS turns positive on the stock: UBS raised its rating on the stock to ‘buy’ from ‘neutral’; and lifted its target price to 600p from 550p. RSA Insurance Group (LON:RSA) is well placed to deliver against lower consensus market expectations as it undergoes a significant year of restructuring, UBS said upgraded its recommendation on the stock. RSA said it had taken actions to address the underperforming areas of the business and expects a “good recovery” in 2019. The broker said that since its last note on RSA, consensus forecasts for earnings per share (EPS) in 2019-20 have fallen by about 4% while the stock trades at a 30% discount to its synthetic sum of the parts valuation. UBS also noted that RSA has announced comprehensive remedial actions across the UK book. “We now find RSA well placed to deliver vs. lower expectations; UBSe 2019-21E EPS is 2-10% ahead of consensus; we believe gradual delivery can help close RSA's execution discount. “We see this as an attractive entry point to a stock with attractive assets, defensive characteristics, self-help and an improving dividend yield underpin.” UBS said it attributes less execution risk to companies that are restructuring and shrinking to greater profitability than those seeking to grow. It said 2019 represents a “significant year of restructuring for RSA” and thinks the company is well placed to deliver on the back of major re-underwriting, re-pricing and enhanced reinsurance purchasing. “We also note UK household trends appear to be stabilising, and there is a pricing tailwind in the London Market,” UBS added. Earnings volatility stemming from the London Market business has sparked concerns around RSA’s ability to lift its payout ratio beyond the 40-50% target. In that context, UBS thinks it is positive RSA has shed 50% of its London Market book and reinsured more out. The investment bank reckons lower volatility should help RSA lift the payout ratio. “Execution is key here, but we expect remedial actions to kick in through 2019. Our 2019 dividend per share expectations are in line, but we're 3% ahead in 2020 and at an estimated 70% pay-out by 2023.”
19/7/2017
07:40
loganair: RSA Insurance Group has performed a significant restructuring program following some fundamental issues a few years ago, streamlining its business, improved its operating performance and balance sheet. Additionally, RSA continues to reach or exceed its financial targets, which bode well for its future prospects. As restructuring is almost completed, RSA’s investment case should move towards income due to its very good dividend growth prospects. It has potential to become a high-dividend yield stock in the next few months, which may also lead to a re-rating of its shares. Geographically, the company has a diversified exposure, with operations in more than 20 countries. However, it is largely focused on the U.K. and some international Northern developed markets. The U.K. segment, including both commercial and personal products, account for 41% of RSA’s premiums, while other important markets are Scandinavia (27% of premiums) and Canada (23%). RSA is now considerably exposed to general insurance markets, which are relatively mature, consolidated and quite stable. This means that, generally speaking, these markets have good returns despite moderate economic growth because established players are usually more focused on profitability rather than volume. This is a recognition that pursuing aggressive growth initiatives in mature markets would likely lead to pricing wars, which ultimately result on lower profitability for the industry as a whole. Taking this into account, RSA targets growth mainly through improved business service and efficiency, such as initiatives to improve customer service and retention, as well as enhance its customer acquisition capabilities. Financially, it targets further underwriting improvement and cost reductions to reach higher earnings in the next few years. Its three core geographies should continue to generate the vast majority of its earnings, with the U.K. and Scandinavia targeted to represent about 80% of its profitability in the coming years. RSA’s recent strong growth is justified mainly by its operating performance, but currency gains were also positive due to the weakening British pound following the Brexit vote. Given that about 70% of RSA’s operating profit is generated outside of the U.K., a weaker currency is positive for its earnings generated abroad. Its return on tangible equity [RoTE] based on underlying earnings was 14.2%, a very good level of profitability and within its new target range of 13-17%, which was achieved one year earlier than expected and upgraded upwards (from RoTE target of 12-15% previously). RSA expects that 2017 should be much less affected by special items and be the last year of material one-off costs, which means that is adjusted and reported earnings should converge in the next couple of years and the difference should be irrelevant thereafter. During the first quarter of the year, RSA only released a ‘trading update’, which confirmed a robust performance, with key indicators continuing to show progress in its business fundamentals. Its net premiums were up by 4% at constant currency rates, being driven by the U.K. (+7% year-on-year) and Canada (+6% yoy), and its operating profit was ahead of its expectations. Going forward, RSA expected to achieve premium growth in the coming years, despite competitive markets across its core businesses. Its priority is to maintain underwriting discipline, which bodes well for its operating earnings sustainability. RSA’s current Solvency II ratio was 158% at the end of 2016, at the top of its target range of 130-160%. Its capitalization has been boosted by good profit generation, but also from balance sheet de-risking due to its disposals. The sale of its U.K. legacy liabilities improved the quality of its capital even further and represented a small boost to its Solvency II ratio, which the company used to buy back debt with high coupon rates. At the end of March 2017, its Solvency II ratio was 166%, which is in-line with its competitors, closing one of its main weak points over the past few years that was its relatively undercapitalization compared to peers. This marks another milestone on its restructuring path, leaving RSA as a properly capitalized insurance company. Additionally, its surplus capital position compared to its regulatory requirement of a Solvency II ratio above 100%, means that RSA doesn’t have regulatory constraints to distribute excess cash to shareholders and should be able to offer an attractive shareholder remuneration policy in the next few years. Based on underlying earnings, its dividend payout ratio was conservative in the past year, given that RSA distributed only 41% of earnings. Its dividend policy is for a payout between 40-50%, plus ‘special’; dividends on a discretionary basis. This seems conservative given that its peers Admiral and Direct Line distribute close to 100% of its earnings to shareholders, showing that RSA has a lot of room to distribute more cash to shareholders. Indeed, according to analysts’ estimates, RSA should deliver solid dividend growth at about 25% per year in the next three years. Its dividend is expected to be about £0.31 ($0.40) per share by 2019, almost double compared to its most recent annual dividend. Despite its good dividend growth expectations, RSA’s dividend payout ratio is expected to increase only to about 55% during the next three years, a level that seems conservative given the company’s strong capitalization and low need to retain earnings. Conclusion: RSA has undergone a significant restructuring of its business over the past few years, which is now almost completed. The company is now in a much more solid position, from an operating and balance sheet standpoint boding well for its growth prospects. Therefore, its investment case should change in the next few months, from a self-help story to an income stock. RSA has very good dividend growth prospects, assuming its conservative payout policy, with plenty of upside to beat expectations due to its good fundamentals and strong capitalization. RSA currently trades at 1.84x book value, representing a valuation discount to its closest peers, which trade on average at about 2.50x book value. This valuation seems to be unwarranted because it reflects more its past performance rather than its improving fundamentals and prospects of becoming a high-dividend yielder in the next couple of years. RSA is currently expected to distribute about 55% of its earnings to shareholders during the next three years, but the company can easily beat these estimates. If RSA becomes a little more aggressive and decides to increase its payout to 70%, which is sustainable given that it doesn’t need to retain earnings going forward, this would lead to a dividend yield of about 5.5%. This would be above the yield of its peer group and possibly would be a positive catalyst for a re-rating of its shares. If RSA’s valuation moves closer to its peers’ average, it has more than 30% upside potential in the next 12-18 months, making it quite attractive from an income perspective and potential capital gains as well.
ADVFN Advertorial
Your Recent History
LSE
RSA
Rsa Insura..
Register now to watch these stocks streaming on the ADVFN Monitor.

Monitor lets you view up to 110 of your favourite stocks at once and is completely free to use.

By accessing the services available at ADVFN you are agreeing to be bound by ADVFN's Terms & Conditions

P: V: D:20201128 09:01:32